Charlotte’s Web Holdings (TSE:CWEB) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Charlotte’s Web Holdings shares promising Phase 1 trial results for AJA001, a botanical drug developed for autism spectrum disorder, showcasing its safety and potential efficacy. The trial leverages a proprietary hemp extract, underscoring the company’s commitment to innovative therapies for underserved conditions.
For further insights into TSE:CWEB stock, check out TipRanks’ Stock Analysis page.